These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

346 related articles for article (PubMed ID: 7882334)

  • 21. Loss of heterozygosity and mutation analysis of the p16 (9p21) and p53 (17p13) genes in squamous cell carcinoma of the head and neck.
    González MV; Pello MF; López-Larrea C; Suárez C; Menéndez MJ; Coto E
    Clin Cancer Res; 1995 Sep; 1(9):1043-9. PubMed ID: 9816078
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chromosome 13q deletion mapping in head and neck squamous cell carcinomas: identification of two distinct regions of preferential loss.
    Maestro R; Piccinin S; Doglioni C; Gasparotto D; Vukosavljevic T; Sulfaro S; Barzan L; Boiocchi M
    Cancer Res; 1996 Mar; 56(5):1146-50. PubMed ID: 8640775
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Deletion mapping of chromosome 4q22-35 and identification of four frequently deleted regions in head and neck cancers.
    Cetin E; Cengiz B; Gunduz E; Gunduz M; Nagatsuka H; Bekir-Beder L; Fukushima K; Pehlivan D; N MO; Nishizaki K; Shimizu K; Nagai N
    Neoplasma; 2008; 55(4):299-304. PubMed ID: 18505340
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Detailed deletion mapping of loss of heterozygosity on 9p13-23 in laryngeal squamous cell carcinoma by microsatellite analysis.
    Xu XF; Gao YN; Cheng SJ
    Chin Med J (Engl); 2004 Aug; 117(8):1204-9. PubMed ID: 15361296
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Distinct regions of loss of heterozygosity on 22q in different sites of head and neck squamous cell carcinomas.
    dos Reis PP; Poli-Frederico RC; dos Santos RM; Nishimoto IN; Kowalski LP; Rogatto SR
    Med Sci Monit; 2002 Mar; 8(3):BR89-94. PubMed ID: 11889455
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Allelotype of head and neck squamous cell carcinoma.
    Nawroz H; van der Riet P; Hruban RH; Koch W; Ruppert JM; Sidransky D
    Cancer Res; 1994 Mar; 54(5):1152-5. PubMed ID: 8118797
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Loss of heterozygosity analysis of a candidate gastric carcinoma tumor suppressor locus at 7q31.
    Xia JC; Weng DS; Li JT; Qin HD; Mai SJ; Feng BJ; Fan Q; Feng QS; Huang LX; Yu XJ; Pan ZZ; Li YQ; Wang QJ; Zhan YQ; Chen SP; He J; Huang WL; Wu PH; Zeng YX
    Cancer Genet Cytogenet; 2006 Apr; 166(2):166-72. PubMed ID: 16631475
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Loss of heterozygosity at 7q31 is a frequent and early event in prostate cancer.
    Latil A; Cussenot O; Fournier G; Baron JC; Lidereau R
    Clin Cancer Res; 1995 Nov; 1(11):1385-9. PubMed ID: 9815935
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differential loss of heterozygosity at 7q31.2 in follicular and papillary thyroid tumors.
    Zhang JS; Nelson M; McIver B; Hay ID; Goellner JR; Grant CS; Eberhardt NL; Smith DI
    Oncogene; 1998 Aug; 17(6):789-93. PubMed ID: 9715281
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Allelic losses at 1p36 and 19q13 in gliomas: correlation with histologic classification, definition of a 150-kb minimal deleted region on 1p36, and evaluation of CAMTA1 as a candidate tumor suppressor gene.
    Barbashina V; Salazar P; Holland EC; Rosenblum MK; Ladanyi M
    Clin Cancer Res; 2005 Feb; 11(3):1119-28. PubMed ID: 15709179
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Meningiomas: analysis of loss of heterozygosity on chromosome 10 in tumor progression and the delineation of four regions of chromosomal deletion in common with other cancers.
    Mihaila D; Gutiérrez JA; Rosenblum ML; Newsham IF; Bögler O; Rempel SA;
    Clin Cancer Res; 2003 Oct; 9(12):4435-42. PubMed ID: 14555516
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Molecular characterization of head and neck tumors by analysis of telomerase activity and a panel of microsatellite markers.
    Fiedler W; Hoppe C; Schimmel B; Koscielny S; Dahse R; Bereczki Z; Claussen U; Ernst G; von Eggeling F
    Int J Mol Med; 2002 Apr; 9(4):417-23. PubMed ID: 11891539
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Localization of a novel tumor suppressor gene associated with human oral cancer on chromosome 4q25.
    Wang XL; Uzawa K; Imai FL; Tanzawa H
    Oncogene; 1999 Jan; 18(3):823-5. PubMed ID: 9989834
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification of a 1300 kilobase deletion unit on chromosome 7q31.3 in invasive epithelial ovarian carcinomas.
    Edelson MI; Scherer SW; Tsui LC; Welch WR; Bell DA; Berkowitz RS; Mok SC
    Oncogene; 1997 Jun; 14(24):2979-84. PubMed ID: 9205105
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Frequent loss of heterozygosity in region of the KIP1 locus in non-small cell lung cancer: evidence for a new tumor suppressor gene on the short arm of chromosome 12.
    Takeuchi S; Mori N; Koike M; Slater J; Park S; Miller CW; Miyoshi I; Koeffler HP
    Cancer Res; 1996 Feb; 56(4):738-40. PubMed ID: 8631006
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A simple specific pattern of chromosomal aberrations at early stages of head and neck squamous cell carcinomas: PIK3CA but not p63 gene as a likely target of 3q26-qter gains.
    Redon R; Muller D; Caulee K; Wanherdrick K; Abecassis J; du Manoir S
    Cancer Res; 2001 May; 61(10):4122-9. PubMed ID: 11358835
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Deletion mapping of chromosome 4 in head and neck squamous cell carcinoma.
    Pershouse MA; El-Naggar AK; Hurr K; Lin H; Yung WK; Steck PA
    Oncogene; 1997 Jan; 14(3):369-73. PubMed ID: 9018123
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Allelic loss and replication errors at microsatellite loci on chromosome 11p in head and neck squamous carcinoma: association with aggressive biological features.
    El-Naggar AK; Hurr K; Huff V; Luna MA; Goepfert H; Batsakis JG
    Clin Cancer Res; 1996 May; 2(5):903-7. PubMed ID: 9816248
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Loss of heterozygosity at chromosome 7q in human breast cancer: association with clinical variables.
    Kristjansson AK; Eiriksdottir G; Ragnarsson G; Sigurdsson A; Gudmundsson J; Barkardottir RB; Jonasson JG; Egilsson V; Ingvarsson S
    Anticancer Res; 1997; 17(1A):93-8. PubMed ID: 9066635
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evidence that loss of chromosome 18q is associated with tumor progression.
    Frank CJ; McClatchey KD; Devaney KO; Carey TE
    Cancer Res; 1997 Mar; 57(5):824-7. PubMed ID: 9041179
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.